A group of researchers from the Goethe University in Frankfurt have found a connection between the vaccine companies AstraZeneca and Johnson & Johnson and the formation of blood clots. This is reported by RBC.
According to Professor Rolf Marschalek, thrombosis is associated with adenoviral vectors, which both vaccines use to deliver the spike protein of the Sars-Cov-2 virus to the human body. According to him, the spike protein is not directed into the cytosolic fluid of a healthy cell (this is where the coronavirus usually produces proteins), but into the nucleus. After that, parts of the spike protein are cleaved and create mutations that cannot bind to the cell membrane and cause immunization. Instead, mutated versions of the protein cause blood clots to form in about one in 100,000 people.
Earlier in the media there was an internal report of the Swedish-British pharmaceutical company AstraZeneca. It states that the number of deaths after the use of the Pfizer coronavirus vaccine in six European countries is significantly higher than after the AstraZeneca vaccine.
In April, several European countries suspended or banned vaccination with AstraZeneca due to the detection of thrombosis in vaccinated patients. At the same time, the creators of the vaccine insist on its safety. The company said that a detailed study of the health status of more than 17 million people after vaccination showed no data on an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia.